UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007121 |
|---|---|
| Receipt number | R000008341 |
| Scientific Title | Evaluation of safety and efficacy of eribulin for patients advanced or recurrent HER2 negative breast cancer who have been treated with anthracyclines and taxanes |
| Date of disclosure of the study information | 2012/01/24 |
| Last modified on | 2018/05/14 16:55:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/01/23 18:27:22 | ||
| 2 | Update | 2012/02/03 09:34:35 | Last name of lead principal investigator Last name of contact person |
|
| 3 | Update | 2012/07/24 16:21:18 | Institutions |
|
| 4 | Update | 2012/09/05 09:53:06 | Institutions |
|
| 5 | Update | 2013/01/25 10:58:38 | Institutions |
|
| 6 | Update | 2014/07/23 10:41:54 | TEL Address Address |
|
| 7 | Update | 2014/07/23 10:43:11 | Recruitment status |
|
| 8 | Update | 2018/05/14 16:54:52 | Recruitment status Publication of results |
|
| 9 | Update | 2018/05/14 16:55:44 | Name of primary person or sponsor Organization |
